Company: HQL
Filing Date: 2025-12-08
Form Type: N-CSR
Source: 0001104659-25-119341
Chunk: 2

Company: abrdn Life Sciences Investors
Filing Date: 2025-12-08
Form: N-CSR
Chunk 2
---
 and market price of the Fund, respectively, compared to the Fund’s benchmark, is as follows:

| NAV2,3                      | 21.06% |
| Market Price2               | 17.62% |
| Nasdaq Biotechnology Index4 | 3.19%  |

For more information about Fund performance, please visit the Fund on the web at www.aberdeenhql.com. Here, you can view quarterly commentary on the Fund's performance, monthly fact sheets, distribution and performance information, and other Fund literature. NAV, Market Price and Premium(+)/Discount(-) The below table represents a comparison between the current fiscal year end and the prior fiscal year end of the Fund's market price to NAV and associated Premium(+) and Discount(-).

|           |    NAV | Closing 
  Market 
   Price | Premium(+)/ 
 Discount(-) |
| 9/30/2025 | $17.35 |  $15.51 | -10.61%     |
| 9/30/2024 | $16.38 |  $15.08 | -7.94%      |

During the fiscal year ended September 30, 2025, the Fund’s NAV was within a range of $12.00 to $17.34 and the Fund’s market price traded within a range of $10.87 to $15.51. During the fiscal year ended September 30, 2025, the Fund’s shares traded within a range of a premium(+)/discount(-) of -12.80% to -6.51%. Aberdeen Name Change On March 4, 2025, abrdn plc, the parent company of the Fund's adviser, announced that it would change its name, and from that date, will use `Aberdeen' as the principal trading identity for its Investments business. On March 12, 2025, abrdn plc completed the steps to legally change its name to Aberdeen Group plc. Aberdeen has retained `abrdn' as an operational abbreviation across its subsidiary legal entities (including the Fund's adviser, fund names and descriptors). Managed Distribution Policy The Fund has a managed distribution policy of paying quarterly distributions at an annual rate, set by the Board of Trustees (the "Board") once a year, as a percentage of the rolling average of the Fund’s NAV over the preceding three month period ending on the last day of the month immediately preceding the distribution’s declaration date. On March 11, 2025,